Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.600 USD | +5.96% | +15.11% | -85.28% |
Aug. 14 | Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy | MT |
Aug. 13 | Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024 |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-0.77x | - | 0.03x | -1.86x | - | 0.64x | - | 85.38M | ||
58.35x | 40.20 | 0.35x | 18.08x | 43.97x | 47.67x | +0.57% | 816B | ||
38.84x | 27.22 | 1.77x | 13.53x | 27.55x | 30.57x | +1.29% | 583B | ||
21.27x | 5.662 | -0.49x | 4.6x | 13.01x | 14.76x | +2.82% | 402B | ||
37.55x | 40.78 | 0.42x | 7.12x | 15.38x | 15.96x | +3.23% | 342B | ||
15.82x | 6.128 | 0x | 5.02x | 11.5x | 13.02x | +2.59% | 300B | ||
16.1x | 5.880 | 0.98x | 3.8x | 9.83x | 11.05x | +3.67% | 255B | ||
28.05x | 5.769 | 0.6x | 5.05x | 15.11x | 15.56x | +1.98% | 243B | ||
21.51x | 5.259 | -0.87x | 4.96x | 12.55x | 13.23x | +3.26% | 235B | ||
51.29x | 35.65 | -1.07x | 6.9x | 12.08x | 15.41x | +2.76% | 179B | ||
21.85x | 1.923 | 0.08x | 3.73x | 10.08x | 12.25x | +5.60% | 169B | ||
19.37x | 1.691 | 0.83x | 2.89x | 10x | 10.92x | +3.76% | 143B | ||
311.63x | 5.364 | -3.31x | 4.39x | 12.06x | 16.4x | +3.66% | 103B | ||
-25.21x | 5.362 | 0.17x | 2.98x | 25.98x | 30.58x | +4.81% | 100B | ||
12.57x | 4.139 | 2.56x | 2.44x | 7.25x | 8.39x | +3.76% | 86.4B | ||
30.52x | 6.026 | 2.57x | 9.19x | 19.35x | 20.73x | +1.29% | 78.3B | ||
42.98x | 5.565 | 4.89x | 4.68x | 26.88x | 35.07x | +1.23% | 65.55B | ||
25.11x | 2.131 | 0.63x | 3.83x | 15.18x | 17.03x | +1.61% | 47.78B | ||
59.14x | 0.9154 | -2.6x | 2.43x | 10.17x | 36.47x | +4.66% | 46.97B | ||
Average | 41.37x | 11.43 | 0.40x | 5.46x | 16.55x | 19.25x | +2.92% | 220.82B | |
Weighted average by Cap. | 40.03x | 19.12 | 0.41x | 8.67x | 21.27x | 23.85x | +2.40% |
- Stock Market
- Equities
- MRNS Stock
- Sector Marinus Pharmaceuticals, Inc.
- Sector valuations